Renal cell therapy and beyond

Seminars in Dialysis

Volumn 22, Issue 6, 2009, Pages 603-609

  Song, Joon Ho ^a,b   Humes, H David ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CYTOKINE; GLUTATHIONE;

ACTIVE TRANSPORT; ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; ARTIFICIAL KIDNEY; BIOARTIFICIAL ORGAN; BLOOD; CYTOLOGY; DISEASE MODEL; HUMAN; IMMUNOLOGY; INSTRUMENTATION; KIDNEY TUBULE; METABOLISM; RENAL REPLACEMENT THERAPY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; BIOARTIFICIAL ORGANS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLECALCIFEROL; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES; KIDNEY, ARTIFICIAL; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 71549166377     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00663.x     Document Type: Article

References (55)

1. Schrier RW, Wang W : Acute renal failure and sepsis. N Engl J Med 351 : 159 169, 2004
2. Breen D, Bihari D : Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int 53 (Suppl. 66 S25 S33, 1998
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR : Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 : 1303 1310, 2001
4. Edelstein CL, Schrier RW : Pathophysiology of ischemic acute renal failure. In : Schrier RW (ed Diseases of the Kidney and Urinary Tract, 7th edn, Vol. 2. Philadelphia : Lippincott Williams & Wilkins, 2001 : 1041 1069
5. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM, for the Program to Improve Care in Acute Renal Disease (PICARD) : Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 66 : 1613 1621, 2004
6. Bone RC, Grodzin CJ, Balk RA : Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112 : 235 243, 1997
7. U.S. Renal Data System : USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
8. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G : Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 356 : 26 30, 2000
9. Schiffl H, Lang SM, Fischer R : Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 : 305 310, 2002 (Pubitemid 34438837)
10. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY : Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70 : 1312 1317, 2006
11. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J : Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30 : 2205 2211, 2002
12. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM : Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19 : 1233 1238, 2008
13. Gillum DM, Dixon BS, Yanover MJ, Kelleher SP, Shapiro MD, Benedetti RG, Dillingham MA, Paller MS, Goldberg JP, Tomford RC : The role of intensive dialysis in acute renal failure. Clin Nephrol 25 : 249 255, 1986
14. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P : Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 : 7 20, 2008
15. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group : Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 : 2010 2019, 2002
16. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 : 1307 1320, 2002
17. Deneke SM, Fanburg BL : Regulation of cellular glutathione. Am J Physiol 257 : L163 L173, 1989
18. Tannen RL, Sastrasinh S : Response of ammonia metabolism to acute acidosis. Kidney Int 25 : 1 10, 1984
19. Maack T : Renal handling of proteins and polypeptides. In : Windhager EE (ed Handbook of Physiology. New York : Oxford University Press, 1992 : 2039 2118
20. Stadnyk AW : Cytokine production in epithelial cells. FASEB J 8 : 1041 1047, 1994
21. Humes HD : Bioartificial kidney for full renal replacement therapy. Semin Nephrol 20 : 71 82, 2000
22. Turpen JB, Knudson CM : Ontogeny of hematopoietic cells in Rana pipiens: precursor cell migration during embryogenesis. Dev Biol 89 : 138 151, 1982
23. Bishop GA, Waugh JA, Hall BM : Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation 46 : 303 310, 1988
24. Wahl P, Schoop R, Bilic G, Neuweiler J, Le Hir M, Yoshinaga SK, Wüthrich RP : Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 13 : 1517 1526, 2002
25. Yard BA, Daha MR, Kooymans-Couthino M, Bruijn JA, Paape ME, Schrama E, van Es LA, van der Woude FJ : IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. Kidney Int 42 : 383 389, 1992
26. Prodjosudjadi W, Gerritsma JS, Klar-Mohamad N, Gerritsen AF, Bruijn JA, Daha MR, van Es LA : Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 48 : 1477 1486, 1995
27. Curthoys NP : Role of γ-glutamyltranspeptidase in the renal metabolism of glutathione. Miner Electrolyte Metab 9 : 236 245, 1983
28. Avissar N, Ornt DB, Yagil Y, Horowitz S, Watkins RH, Kerl EA, Takahashi K, Palmer IS, Cohen HJ : Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 266 (2 Pt 1 C367 C375, 1994
29. Zimerman JJ : Defining the role of oxyradicals in the pathogenesis of sepsis. Crit Care Med 23 : 616 617, 1995
30. Ross EA, Koo LC, Moberly JB : Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 30 : 489 494, 1997
31. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF : Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 303 : 98 106, 1993
32. Bikle DD : Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocrine 13 : 765 784, 1992
33. Bhalla AK : Hormones and the immune response. Ann Rheum Dis 48 : 1 6, 1989
34. Sullivan R, Fredette JP, Griffin JD, Leavitt JL, Simons ER, Melnick DA : An elevation in the concentration of free cytosolic calcium is sufficient to activate the oxidative burst of granulocytes primed with recombinant human granulocyte-macrophage colony-stimulating factor. J Biol Chem 264 : 6302 6309, 1989
35. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E : Serum cytokine levels in human septic shock. Chest 103 : 565 576, 1993
36. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, Cavaillon JM : Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88 : 1747 1754, 1991
37. Astiz M, Saha D, Lustbader D, Lin R, Rackow E : Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 128 : 594 600, 1996
38. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH : Immunologic function and survival in hemodialysis patients. Kidney Int 54 : 236 244, 1998
39. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL : Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 : 107 114, 1998
40. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS : Hypovitaminosis D in medical inpatients. N Engl J Med 338 : 777 783, 1998
41. Humes HD, Fissell WH, Weitzel WF : The bioartificial kidney in the treatment of acute renal failure. Kidney Int 61 (Suppl. 80 S121 S125, 2002
42. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF : Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17 : 451 455, 1999
43. Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM : Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 39 : 1078 1087, 2002
44. Fissell WH, Dyke DB, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM, Humes HD : Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif 20 : 55 60, 2002
45. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD : Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 14 : 454 461, 2003
46. Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH : Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 31 : 2421 2428, 2003
47. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J : Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 66 : 1578 1588, 2004
48. Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD : Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 19 : 1034 1040, 2008
49. Berliner JA, Heinecke JW : The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20 : 707 727, 1996
50. Revillard IP, Vincent C : Structure and metabolism of beta2-microglobulin. Contrib Nephrol 62 : 44 53, 1988
51. Kaneider NC, Leger AJ, Kuliopulos A : Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions. FEBS J 273 : 4416 4424, 2006
52. Maroszynska I, Fiedor P : Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemia-reperfusion injury. Ann Transplant 5 : 5 11, 2000
53. Gu YJ, deVries AJ, Boonstra PW, van Oeveren W : Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 112 : 494 500, 1996
54. Ding F, Song JH, Lou L, Rojas A, Reoma J, Cook K, Smith P, Buffington D, Humes HD : A novel selective cytopheretic inhibitory device (SCD) inhibits circulating leukocyte activation and ameliorates multiorgan dysfunction in a porcine model of septic shock (Abstract). J Am Soc Nephrol 19 : 458A, 2008
55. Humes HD, Dillon J, Tolwani A, Cremisi H, Wali R, Murray P, Ye J, Chawla LS, Vijayan A, Finkel KW, Kraus MA, Atta M, Von Visger J, Block GA, Charytan D, Vinnikova AK : A novel selective cytopheretic inhibitory device (SCD) improves mortality in ICU patients with acute kidney injury (AKI) and multiorgan failure (MOF) in a phase II clinical study (Abstract). J Am Soc Nephrol 19 : 458A, 2008